With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.
Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 270 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.
We can advise you on:
If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.
An international overview of the regulatory legislation
LMG Life Sciences Awards EMEA 2022
Two Impact Case of the Year Awards
- CE - 450163 Doctolib successful before Conseil d'État
- Pharmaceutical Works Polpharma SA v European Medicines Agency (EMA).
Managing Intellectual Property
Impact Case of the Year
Shenzen Senior Technology
Material Co v Celgard
Managing Intellectual Property EMEA Awards 2021